Additional file 4 of Candidate methylation sites associated with endocrine therapy resistance in ER+/HER2- breast cancer

  • Pernette J. Verschure (Contributor)
  • Maryam Soleimani Dodaran (Contributor)
  • Simone Borgoni (Contributor)
  • Antoine H C van Kampen (Contributor)
  • Emre Sofyall (Contributor)
  • Perry D Moerland (Contributor)
  • Stefan Wiemann (Contributor)

Dataset

Description

Additional file 4. Single-locus survival analysis. Results of single-locus survival analysis on ER+/HER2-, TAM and AI cohorts. For each CpG the results of the correlation analysis and of the differential methylation analysis of month 7 versus WT in the T47D RA experiment are also included.
Date made available1 Jan 2020
Publisherfigshare Academic Research System

Cite this